Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Cadsys India IPO and Trident Texofab IPO.
Cadsys India IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Trident Texofab IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Cadsys India IPO | Trident Texofab IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Saffron Capital Advisors Private Limited | Guiness Corporate Advisors Pvt Ltd |
| Registrar | Bigshare Services Pvt Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
|
| RHP | RHP |
|
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Cadsys India IPO is up to ₹14.70 Cr whereas the issue size of the Trident Texofab IPO is up to ₹3.53 Cr. The final issue price of Cadsys India IPO is ₹70.00 per share and of Trident Texofab IPO is ₹30.00 per share.
| Cadsys India IPO | Trident Texofab IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹70.00 per share | ₹30.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 21,00,000 shares | 11,76,000 shares |
| Issue Size Total (Amount) | up to ₹14.70 Cr | up to ₹3.53 Cr |
Cadsys India IPO opens on Sep 21, 2017, while Trident Texofab IPO opens on Sep 21, 2017. The closing date of Cadsys India IPO and Trident Texofab IPO is Sep 25, 2017, and Sep 26, 2017, respectively.
| Cadsys India IPO | Trident Texofab IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 21, 2017 | Sep 21, 2017 |
| Issue Close | Sep 25, 2017 | Sep 26, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Cadsys India IPO P/E ratio is , as compared to Trident Texofab IPO P/E ratio of .
| Cadsys India IPO | Trident Texofab IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Cadsys India IPO retail investors (RII) are offered while in Trident Texofab IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Cadsys India IPO and in Trident Texofab IPO.
| Cadsys India IPO | Trident Texofab IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Cadsys India IPO subscribed in total, whereas Trident Texofab IPO subscribed .
| Cadsys India IPO | Trident Texofab IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
